Posted 19th December 2018 by Kieran Chambers
As the world becomes increasingly aware of the important role that different bacterial ecosystems play with regards to human and animal health, there is a growing wealth of research coming out of the microbiome industry. Kristina Campbell & Marilyn White, of KC Microbiome, conducted these interviews at the Microbiome R&D and Business Collaboration Forum: USA.
Posted 17th December 2018 by Kieran Chambers
As industry developments continue to improve, the potential for personalised medicine and the possibility of individual diagnosis is on the horizon. These slides, from the Precision Medicine & Biomarkers Leaders Summit: Europe are now available from Andres Hurtado-Lorenzo, Thorsten Gutjahr & Thomas Skot Jensen.
Posted 12th December 2018 by Kieran Chambers
As a result of revolutionary breakthroughs in recent years, plant research has evolved dramatically. At the 6th Plant Genomics & Gene Editing Congress: USA, the latest NGS, “omic” and gene editing technologies being used for progressing plant based research were examined. If you weren’t able to be there in person, these slides are now available from Sharon Doty, James White & Axel Visel.
Neurobehavioural Screening, Microfabricated Platforms and Medical Device Innovation with Microfluidics
Posted 10th December 2018 by Kieran Chambers
Microfluidics is revolutionising the way patients are diagnosed, monitored and treated. If you weren’t able to attend the 4BIO Summit in San Francisco, we have made these presentation slides from Suvajyoti Guha, Dr Todd Thorsen & Pouya Rezai available here.
Posted 7th December 2018 by Kieran Chambers
The consumption of a healthy diet in combination with regular physical exercise is essential for an optimal and healthy condition, keeping the body in good shape. Although dietary guidelines may help in defining what is a healthy diet, the term healthy not only depends on individual needs and/or opinions.
Posted 5th December 2018 by Kieran Chambers
2018 will be remembered as a decisive year for immuno-oncology. In particular, Nobel Prize winners James Allison of MD Anderson Cancer Center in Houston, Texas, and Tasuku Honjo of Kyoto University in Japan lifted the field of immunotherapy to international recognition for those outside the scientific and medical communities. For the patient, these new alternatives to standard oncology therapies offer new hope for life-extending treatments using immunotherapy.
Posted 3rd December 2018 by Kieran Chambers
The bacterial nature of a plant disease was first proven in 1878–1880 by T. J. Burrill in the University of Illinois when studying fire blight. The number of known species of pathogenic bacteria is in constant change due to the clarification of phylogenetic relatedness upon receipt of new data, but as of 2014 the number of phytopathogenic bacteria genera that unite them was 39 1.
Posted 30th November 2018 by Kieran Chambers
The Fatty Liver Foundation exists because I was not willing to be a well behaved member of the parade of misery that liver disease is becoming for our society. My bucket list includes not dying of liver disease.